🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 día
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/12/2006 | 29,08 | 29,10 | 28,57 | 29,01 | +0,22% | 1,82% | 1.096.400 |
| 04/12/2006 | 29,00 | 29,08 | 28,83 | 28,94 | +0,02% | 0,84% | 716.400 |
| 01/12/2006 | 29,10 | 29,31 | 28,60 | 28,94 | -0,60% | 2,44% | 1.239.000 |
| 30/11/2006 | 29,07 | 29,39 | 28,83 | 29,11 | -0,27% | 1,91% | 1.287.400 |
| 29/11/2006 | 28,36 | 29,30 | 28,27 | 29,19 | +3,11% | 3,63% | 2.862.000 |
| 28/11/2006 | 28,41 | 28,52 | 27,97 | 28,31 | -0,32% | 1,94% | 1.129.400 |
| 27/11/2006 | 28,98 | 29,21 | 28,22 | 28,40 | -2,17% | 3,42% | 910.400 |
| 24/11/2006 | 28,94 | 29,12 | 28,63 | 29,03 | -0,02% | 1,68% | 231.400 |
| 22/11/2006 | 29,27 | 29,34 | 28,90 | 29,04 | -0,50% | 1,50% | 409.200 |
| 21/11/2006 | 29,67 | 29,70 | 28,88 | 29,18 | -0,73% | 2,78% | 1.234.800 |
| 20/11/2006 | 29,53 | 29,88 | 28,94 | 29,40 | -0,20% | 3,20% | 1.829.600 |
| 17/11/2006 | 29,12 | 29,58 | 28,81 | 29,46 | +1,17% | 2,66% | 1.326.200 |
| 16/11/2006 | 28,63 | 29,15 | 28,36 | 29,12 | +1,61% | 2,78% | 1.041.400 |
| 15/11/2006 | 28,49 | 29,07 | 28,41 | 28,66 | +1,08% | 2,32% | 1.437.200 |
| 14/11/2006 | 28,43 | 28,66 | 28,10 | 28,35 | -0,51% | 1,99% | 1.358.200 |
| 13/11/2006 | 28,89 | 29,11 | 28,09 | 28,50 | -1,49% | 3,51% | 2.324.600 |
| 10/11/2006 | 29,03 | 29,18 | 28,59 | 28,93 | +0,00% | 2,03% | 798.200 |
| 09/11/2006 | 29,35 | 29,38 | 28,59 | 28,93 | -1,23% | 2,69% | 1.164.600 |
| 08/11/2006 | 29,08 | 29,42 | 28,70 | 29,29 | +0,39% | 2,46% | 906.800 |
| 07/11/2006 | 29,18 | 30,01 | 29,02 | 29,17 | +0,02% | 3,41% | 1.384.600 |
| 06/11/2006 | 29,32 | 29,38 | 28,94 | 29,17 | -0,53% | 1,50% | 1.800.400 |
| 03/11/2006 | 29,73 | 29,97 | 29,19 | 29,32 | -2,07% | 2,62% | 1.977.000 |
| 02/11/2006 | 29,89 | 30,04 | 29,46 | 29,94 | -0,18% | 1,96% | 1.129.800 |
| 01/11/2006 | 30,10 | 30,62 | 29,89 | 30,00 | +0,23% | 2,43% | 1.928.600 |
| 31/10/2006 | 30,22 | 30,75 | 29,68 | 29,93 | -1,40% | 3,52% | 1.496.800 |
| 30/10/2006 | 30,52 | 30,57 | 29,91 | 30,35 | -0,54% | 2,15% | 1.076.800 |
| 27/10/2006 | 30,70 | 31,24 | 30,27 | 30,52 | -0,52% | 3,18% | 1.167.800 |
| 26/10/2006 | 30,76 | 30,82 | 30,19 | 30,68 | +0,18% | 2,05% | 1.993.600 |
| 25/10/2006 | 31,04 | 31,70 | 30,27 | 30,62 | -1,50% | 4,61% | 5.411.200 |
| 24/10/2006 | 29,90 | 31,38 | 29,86 | 31,09 | +9,05% | 5,07% | 4.938.400 |